Horizon Discovery Microinjection-Ready Cas9 Accelerate RNP
Horizon Discovery has launched a microinjection-ready Cas9 Accelerate Ribonucleoprotein (RNP).
The product sidesteps the transcription and translation steps that CRISPR/Cas9 systems delivered by plasmid and mRNA formats must undergo before engaging in gene editing.